Stockreport

VBL Therapeutics Announces Year Ended December 31, 2019 Financial Results and Provides Corporate Update

Vascular Biogenics Ltd. - Ordinary Shares  (VBLT) 
Last vascular biogenics ltd. - ordinary shares earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: vblrx.com
PDF The OVAL Phase 3 potential-registration study of VB-111 in ovarian cancer continues as planned towards the important interim analysis in 1Q 2020VB-111 clinical program e [Read more]